candesartan has been researched along with Anterior Fascicular Block in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme randomised 7599 patients with symptomatic HF to receive candesartan or placebo." | 3.74 | Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. ( Dunn, FG; Granger, CB; Hawkins, NM; McMurray, JJ; Michelson, EL; Ostergren, J; Pfeffer, MA; Pocock, SJ; Swedberg, K; Wang, D; Yusuf, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, H | 1 |
| Hiraishi, M | 1 |
| Miyoshi, T | 1 |
| Tsuji, T | 1 |
| Kaneko, A | 1 |
| Ryo, K | 1 |
| Yamawaki, K | 1 |
| Fukuda, Y | 1 |
| Norisada, K | 1 |
| Tatsumi, K | 1 |
| Matsumoto, K | 1 |
| Kawai, H | 1 |
| Hirata, K | 1 |
| Hawkins, NM | 1 |
| Wang, D | 1 |
| McMurray, JJ | 1 |
| Pfeffer, MA | 1 |
| Swedberg, K | 1 |
| Granger, CB | 1 |
| Yusuf, S | 1 |
| Pocock, SJ | 1 |
| Ostergren, J | 1 |
| Michelson, EL | 1 |
| Dunn, FG | 1 |
2 other studies available for candesartan and Anterior Fascicular Block
| Article | Year |
|---|---|
Exercise-induced left bundle branch block and subsequent mechanical left ventricular dyssynchrony--resolved with pharmacological therapy.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bundle-Branch Block; Carbazoles; Carved | 2011 |
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Bundle-Branch Blo | 2007 |